Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Departure of Chief Medical Officer
Effective as of April 15, 2022 (the "Separation Date"), Samuel Barone, M.D. will
depart as the Chief Medical Officer of Gemini Therapeutics, Inc. (the
"Company"). Dr. Barone will receive a retention bonus and severance benefits in
accordance with the Retention Agreement, by and between the Company and
Dr. Barone, dated October 4, 2021 (the "Retention Agreement"), which provides
that Dr. Barone is entitled to receive (i) a lump sum amount equal to nine
(9) months of his base salary, (ii) a pro rata portion of his target bonus (as
defined in his employment agreement) for 2022 (the calendar year in which the
last day of his employment occurs), and (iii) monthly COBRA premiums paid by the
Company until the earlier of (a) nine (9) months from the Separation Date,
(b) the date Dr. Barone becomes eligible for health insurance through another
employer, or (c) the cessation of Dr. Barone's continuation coverage rights
under COBRA. The Retention Agreement also contains a reaffirmation of
Dr. Barone's confidentiality and restrictive covenant obligations to the Company
and a general release of claims by Dr. Barone. Dr. Barone will continue to
contribute to the Company in an advisory role for a period of time following the
Separation Date pursuant to an advisory agreement by and between the Company and
Dr. Barone (the "Advisory Agreement"), during which time he will continue to
vest in his existing equity awards.
The foregoing summary does not purport to be complete and is qualified in its
entirety by the Retention Agreement, a copy of which was filed as Exhibit 10.1
to the Company's quarterly report on Form 10-Q filed on November 15, 2021, and
is incorporated herein by reference, and the Advisory Agreement, a copy of which
will be filed as an exhibit to the Company's Form 10-Q for the quarter ended
March 31, 2022.
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses